Navigation Links
Aware, Inc. Reports First Quarter 2011 Financial Results
Date:4/26/2011

erty of their respective owners.AWARE, INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months Ended March 31, 20112010Revenue:Product sales

$5,078$4,651Services

829209Royalties

451756Total revenue

6,3585,616Costs and expenses:Cost of product sales (1)

1,2201,036Cost of services (1)

35772Research and development (1)

1,9612,035Selling and marketing (1)

1,0511,066General and administrative (1)

1,1971,402Total costs and expenses

5,7865,611Income from operations

5725Interest income

2018Income before provision for income taxes

59223Provision for income taxes

21Net income  

$590$22Net income – basic

$0.03$0.00Net income – diluted  

$0.03$0.00Weighted average shares – basic

20,21919,913Weighted average shares – diluted

20,82819,923(1) The amounts in the tables above include stock-based compensation as follows (in thousands):Three Months Ended March 31,20112010Cost of product sales

$2$2Cost of services

96Research and development

67114Sales and marketing

2238General and administrative

203185Total stock-based compensation costs

$303$345AWARE, INC.NON-GAAP FINANCIAL MEASURES AND RECONCILIATION(In thousands, except per share data)(unaudited)Three Months Ended March 31,20112010GAAP net income  

$590$22Stock-based compensation

303345Non-GAAP net income  

$893$367Three Months Ended March 31,20112010GAAP diluted net income per share

$0.03$0.00Stock-based compensation per share

0.010.02Non-GAAP diluted net income per share

$0.04$0.02AWARE, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)March 31, 2011December 31, 2010ASSETSCash and investments

$40,015$39,949Accounts receivable, net

6,1204,968I
'/>"/>

SOURCE Aware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
2. Aware, Inc. Commences Dutch Auction Tender Offer
3. Aware, Inc. Commences Dutch Auction Tender Offer
4. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
5. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Q1 09 Earnings Conference Call
8. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
9. Aware, Inc. Reports First Quarter 2009 Financial Results
10. Aware, Inc. Reports First Quarter 2009 Financial Results
11. Aware, Inc. Announces Q209 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Researchers reporting in the Cell Press journal Current ... insects with rather novel sex lives. The Brazilian insects, ... genus Neotrogla , are the first example of ... reversal has been identified in several different animals, ... intromittent organ is also reversed," says Kazunori Yoshizawa from ...
(Date:4/17/2014)... of Texas Medical Branch at Galveston are the ... radiation for cervical cancer should begin colorectal cancer ... UTMB researchers, finding a high incidence of secondary ... radiation, offer new recommendations that the younger women ... eight years after their initial cervical cancer diagnosis ...
(Date:4/17/2014)... National University (ANU), have developed a new way ... over the past 5.3 million years., The findings ... ice ages over the past two million years, ... dioxide levels, global temperatures and sea levels., The ... and the National Oceanography Centre (NOC) in the ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2Ancient sea-levels give new clues on ice ages 2
... discovered a bone from a pterosaur (giant flying reptile or ... Velociraptor (small predatory theropod dinosaur) that lived in ... The findings published online in Palaeogeography, Palaeoclimatology, and ... carnivore with a specialised sickle shaped slashing talon on the ...
... new research discovery by a team of Stanford and European ... day be able to avoid limb amputation related to ischemia. ... FASEB Journal suggests that the delivery of genes ... and "VEGF" may successfully cause the body to grow new ...
... why immune cells, called T-cells, attack the body is ... University of Alberta researcher Troy Baldwin is a step ... healthy cells causing autoimmune diseases. , Baldwin and ... Bim, which is vital in regulating T-cell death. When ...
Cached Biology News:Dinosaur fossil: Even specialized predators didn't turn down free meals 2Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs 2U of Alberta researcher steps closer to understand autoimmune diseases 2
(Date:1/14/2014)... Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), ... commercializing innovative therapies addressing major unmet medical needs ... the Notice of Allowance from the United States ... RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. ...
(Date:1/14/2014)... Kinaxis ®, provider of RapidResponse ®, a cloud-based supply ... ( S&OP ) service, is proud to be a gold ... held at the Hilton San Diego Bayfront, January 30 – ... Kaszas , Director of Supply Chain at Amgen, as she ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
(Date:1/14/2014)... 14, 2014 Independent publisher Bitingduck Press, ... Montreal, Canada, has big ideas for 2014 in production ... goals are to produce high-quality, low-cost, DRM-free ebooks and ... businesses. , The first major development will be ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky One ... a,leading fully integrated pharmaceutical company producing over-the-counter,drugs in the ... for the fourth quarter and fiscal year ended December ... Highlights, -- Total revenues increased 104.0% ...
... pleased to announce,that its licensee Daiichi Sankyo (Tokyo, ... TwinCaps(R) dry powder inhaler device in the launch ... active,against the influenza virus. Daiichi Sankyo has completed ... and other Asian countries and results,are expected to ...
... to Focus on Drug Development for Neurological ConditionsBROOMFIELD, ... company delivering breakthrough therapies in central nervous system ... Pharmaceuticals, Inc., a drug development company. The ... development of proprietary small molecule drugs for acute ...
Cached Biology Technology:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 2China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 4China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 5China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 6China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 7China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 8China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 9China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 10Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 2Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 3Accera, Inc. Launches Neuera Pharmaceuticals, Inc. 2Accera, Inc. Launches Neuera Pharmaceuticals, Inc. 3
... Detection of the yolk protein Vtg in ... simple and sensitive biomarker for endocrine disrupting chemicals ... Vtg has become an accepted screening test for ... Vtg (rainbow trout) EIA kit is a double-antibody ...
... Laboratory (RTL) can provide you with ... ,,Microbial method development and validation ,Performance ... conditions of your GMP manufacturing environment ... offer a full spectrum of microbiological ...
... amino acid synthetic peptide whose sequence is from rat SCAMP 5. ... C - N(217) - Q - P - Q - ... - P - N - Y - T - Y - ... neutralization and control experiments with the polyclonal antibody that reacts with ...
... (gram quantities of IgY) , After we receive ... we segregate the appropriate number of chickens and ... eggs are collected (usually over a period of ... involves a total of four injections into the ...
Biology Products: